> Skip repeated content

Pilot Study to Evaluate Cosentyx in Bone Health of AS Patients

Ankylosing Spondylitis News—August 8, 2018

Ankylosing Spondylitis News reported that HSS rheumatologist Susan M. Goodman, MD, and a team of researchers are investigating how secukinumab affects bone health in patients with ankylosing spondylitis (AS).

According to the article, the study is expected to last for two years.

"It’s very important to get a better understanding in a practical way of the effect of these drugs on bone metabolism. This study should really help us understand how they work," said Dr. Goodman in a press release.

Read the full article at ankylosingspondylitisnews.com.

 

Need Help Finding a Physician?

Call us toll-free at:
+1.877.606.1555

Conditions & Treatments

adult child
Select A Body Part
Conditions: Adult head Conditions: Adult spine Conditions: Adult shoulder Conditions: Adult elbow Conditions: Adult hand Conditions: Adult hip Conditions: Adult knee Conditions: Adult ankle Conditions: Adult head Conditions: Adult full body Conditions: Child spine Conditions: Child elbow Conditions: Child hip Conditions: Child hand Conditions: Child knee Conditions: Child ankle Conditions: Child full body


Conditions A-Z
A B C D E F G H I
J K L M N O P Q R
S T U V W X Y Z
SEE ALL

Media Contacts

Tracy Hickenbottom
Monique Irons
Sherry Randolph

212.606.1197
mediarelations@hss.edu

Social Media Contacts